https://taxispharma.com/who-names-taxis-txa709-as-one-of-only-2-out-of-26-antibacterials-meeting-all-innovation-criteria/ 2025-02-20T21:06:18+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-appears-in-august-special-issue-on-antibiotic-alternatives-in-acs-infectious-diseases/ 2024-11-07T21:04:12+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-publishes-on-efflux-pump-inhibitors-in-mdpi-journal-antibiotics/ 2024-10-24T21:51:20+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-publishes-on-ftzs-inhibitors-in-nature-the-journal-of-antibiotics/ 2024-10-22T21:15:34+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-announces-2-67-million-nih-grant-to-advance-research-and-development-of-combination-therapy-to-combat-antibiotic-resistant-pneumonia/ 2024-10-14T16:31:25+00:00 monthly 0.6 https://taxispharma.com/overcoming-antibiotic-resistance-breathing-new-life-into-old-medications/ 2024-09-06T15:53:00+00:00 monthly 0.6 https://taxispharma.com/regarding-the-recent-house-budget-committee-roundtable-on-the-threat-of-antibiotic-resistance/ 2024-11-07T18:33:52+00:00 monthly 0.6 https://taxispharma.com/authority-magazine-interview/ 2024-10-24T16:27:30+00:00 monthly 0.6 https://taxispharma.com/the-science-behind-superbugs-the-path-to-new-solutions-in-the-fight-against-antimicrobial-resistance/ 2024-11-12T16:58:36+00:00 monthly 0.6 https://taxispharma.com/podcast-interview-caretalk-healthcare-unfiltered/ 2024-10-10T20:51:21+00:00 monthly 0.6 https://taxispharma.com/genetic-engineering-biotechnology-news-the-antimicrobial-resistance-crisis/ 2025-07-16T16:27:51+00:00 monthly 0.6 https://taxispharma.com/contagion-live-funding-isnt-everything-bringing-pharma-to-the-table-for-the-pasteur-act/ 2024-10-14T17:35:00+00:00 monthly 0.6 https://taxispharma.com/antimicrobial-resistance-amr-white-paper/ 2024-11-18T18:51:25+00:00 monthly 0.6 https://taxispharma.com/innovative-approaches-to-antibiotic-resistance-the-promise-of-txa709/ 2024-12-17T18:07:27+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-receives-2-9-million-nih-grant-for-its-novel-investigational-therapeutic-to-combat-antibiotic-resistant-gonorrhea/ 2025-07-16T01:51:38+00:00 monthly 0.6 https://taxispharma.com/tackling-antimicrobial-resistance-with-precision-targeting-in-drug-discovery-online/ 2025-07-16T02:17:38+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-names-joe-depinto-mba-and-frank-carlo-pasqualone-mba-to-its-board-of-directors/ 2025-07-16T02:00:35+00:00 monthly 0.6 https://taxispharma.com/contagion-live-a-group-of-antimicrobial-compounds-shows-novelty-action-against-multidrug-resistant-gonorrhea/ 2025-07-27T17:33:18+00:00 monthly 0.6 https://taxispharma.com/turning-the-tide-innovations-in-the-fight-against-super-gonorrhea/ 2025-07-24T20:52:07+00:00 monthly 0.6 https://taxispharma.com/hospital-acquired-pneumonia-rethinking-treatment-in-the-face-of-antibiotic-resistance/ 2025-07-24T21:04:14+00:00 monthly 0.6 https://taxispharma.com/smart-investing-in-antimicrobial-resistance-solutions-disrupts-biotech-market/ 2025-09-08T16:03:44+00:00 monthly 0.6 https://taxispharma.com/how-innovation-is-turning-the-tide-in-the-costly-fight-against-antimicrobial-resistance/ 2025-09-08T16:09:09+00:00 monthly 0.6 https://taxispharma.com/podcast-interview-the-bio-report-overcoming-antibiotic-resistance/ 2025-09-10T20:43:21+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-responds-to-cdc-report-on-surge-in-antibiotic-resistant-bacteria/ 2025-09-25T14:59:54+00:00 monthly 0.6 https://taxispharma.com/contagion-live-addressing-resistance-to-pathogens-like-ndm-cre-through-the-lens-of-antimicrobial-development/ 2025-10-28T02:03:56+00:00 monthly 0.6 https://taxispharma.com/the-rise-of-antimicrobial-resistance-and-strategic-research-imperatives-for-2026/ 2026-01-05T19:35:18+00:00 monthly 0.6 https://taxispharma.com/charting-the-future-of-antimicrobial-resistance/ 2026-01-21T18:16:24+00:00 monthly 0.6 https://taxispharma.com/absence-of-a-widespread-infectious-disease-emergency-in-2025-has-hindered-progress-in-combating-amr/ 2026-02-02T15:21:40+00:00 monthly 0.6 https://taxispharma.com/taxis-pharmaceuticals-names-angela-fonceca-phd-to-its-australian-board-of-directors/ 2026-02-12T13:41:21+00:00 monthly 0.6 https://taxispharma.com/world-health-day-2026/ 2026-03-24T20:01:18+00:00 monthly 0.6 https://taxispharma.com/antibiotic-resistant-gonorrhea-emerges-as-a-growing-mens-health-crisis-during-sti-awareness-month/ 2026-04-02T20:24:33+00:00 monthly 0.6